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Abstract 
Extent of enhancing tumour 
resection is correlated with 
progression free survival 
following glioma surgery. 
Historically, a contrast 
enhanced MRI has been 
recommended within 72 
hours following surgery to 
evaluate for residual disease. 
This theoretical window was 
established amidst conflicting 
evidence to avoid reactive 
enhancement. Recent studies 
with better designs and better 
imaging quality have sought 
to challenge this window with 
a more pragmatic method of 
evaluating residual disease. 





Glioblastoma remains the most common primary central 
nervous system malignancy with poor outcomes despite 
standard of care treatment. The extent of resection of 
these tumours dictates prognosis and outcome. This has 
been demonstrated by several studies over a period of 
many years.1 Several follow up studies have linked 
removal of the enhancing part of the tumour with 
survival. In cases where total removal is not possible, the 
volume of the remaining enhancing tumour is correlated 
with survival.2 Further care of these patients is decided 
upon post-operative imaging to assess residual disease. 
Over time there has been consensus to acquire this 
imaging within a 72 hour post-operative window because 
after this time there is development of benign contrast 
enhancement that can be confused with residual 
disease.3 Herein, the authors review the existing literature 
on the optimal timing of post-operative MRI after glioma 
surgery. 
Review of Evidence 
In the late 1970s and early 1980s, the debate of whether 
extent of resection influences outcomes in patients with 
glioblastomas was raging. Several studies had failed to 
demonstrate any improved outcome with more radical 
excision versus biopsy. However, several other authors 
described improved outcomes following more extensive 
resection.4,5 In their recently published perspective piece, 
Grasso et al., have described briefly the clear advantage 
afforded by gross total resection of the enhancing part of 
the tumour when compared with incomplete resection.6 
There are now studies also showing a clear benefit of 
supramaximal resection of the T2 abnormality area 
beyond the enhancing part.7 
The current modality of choice for determining extent 
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Figure 1a and 1b: Postoperative 1.5 T MRI (T1WI) axial pre and post-contrast, done within 24 hours of surgery, of a patient who 
underwent debulking surgery for a recurrent glioblastoma. In figure 1a, the hyperintense signals in the resection bed are 
representative of post-surgical changes. In figure 1b, the single thick white line shows 3.5mm thin linear enhancement especially 
at its widest part that is consistent with reactive enhancement. The two thick white lines show enhancement in the residual tumour.
of resection following glioblastoma surgery is MRI with 
contrast. The timing of this scan is debated amongst 
neurosurgeons and radiologists. The current standard 
has been set at <72 hours post-surgery based on early 
studies.3 Henegar et al., were the first to describe post-
operative MRI changes following non neoplastic brain 
parenchyma resection and enhancement patterns that 
occur as a result of surgery itself.8 Ekinci et al., 
published a detailed account of early post-operative 
MRI (EPMR) changes following tumour resection in the 
first 12-24 hours following surgery.9 They designed this 
study to avoid reactive enhancement that had been 
shown to develop even prior to 72 hours and described 
three patterns of enhancement, thin linear (normal 
dural enhancement), thick linear (likely neoplastic) 
and thick linear-nodular (likely residual) and examined 
their relationship with disease recurrence and 
progression.9 Prior to this study it was believed that 
there was a 72 hour diagnostic window where all 
enhancement was due to residual disease. It was 
found that enhancement in some form exists at even 
less than 24 hours following surgery however the 
pattern of this enhancement was deemed to be 
important.9 Lescher et al., demonstrated that patterns 
of enhancement are influenced by field strengths as 
well. They also showed that nonspecific enhancement 
occurs prior to the stipulated 72 hour window and is 
also influenced by pre-operative or intra-operative 
contrast administration. It was therefore advised to 
compare pre-operative and post-operative scans to 
identify a residual enhancing tumour.10 
Bette et al., recently described in detail the pattern and 
time dependence of nonspecific enhancement following 
glioma surgery on 3T MRI scanners. Their data showed 
that enhancement occurred at all time periods, and even 
as early as 17 hours post-surgery. Their results however 
showed a significant increase in enhancement after 45 
hours.11 
We would like to mention a new modality that has recently 
come to the fray for postoperative glioblastoma imaging. 
O-(2-18Ffluoroethyl)-L-tyrosine positron emission 
tomography (FET-PET) has been shown to identify areas of 
residual disease that are not obvious even on EPMR. These 
areas have a demonstrable high risk of recurrence of 
disease.12 
Conclusion 
Based on the available evidence, we conclude that post-
operative imaging in case of glioma surgery should be 
acquired as early as possible and any enhancement 
observed should be carefully compared with pre-
operative imaging to delineate true residual disease from 
reactive enhancement that is invariably present in the 
post-operative environment. MRI done beyond 72 hours 
becomes increasingly unreliable. It would also be prudent 
to use the same scanner and field strength when 
acquiring images.   
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